News Avulux Earns FDA Clearance, Establishing First Device Classification for Migraine Light SensitivityHealthradar27. August 2026 What You Should Know The U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization to Avulux, establishing…
